Preformulation studies of Clostridium difficile toxoids A and B

Area of Science:

• Biochemistry
• Pharmaceutical Sciences
• Vaccine Development

Background:

• Clostridium difficile toxoids A and B are crucial vaccine components.
• Enhancing the physical stability of these toxoids is essential for effective pharmaceutical formulations.
• Understanding toxoid behavior under various conditions is key to stability.

Purpose of the Study:

• To screen for compounds that enhance the physical stability of Clostridium difficile toxoids A and B.
• To identify stabilizing excipients for improved vaccine formulation.
• To investigate toxoid behavior under stress conditions.

Main Methods:

• Screening of 30 Generally Recognized As Safe (GRAS) compounds using high-throughput aggregation assays.
• Assessing compound efficacy at various concentrations and combinations.
• Evaluating compound ability to delay unfolding under specific pH and temperature conditions.
• Monitoring thermal stability of toxoids on Alhydrogel using Differential Scanning Calorimetry (DSC).

Main Results:

• Several GRAS compounds demonstrated significant stabilization of Clostridium difficile toxoids A and B.
• Compounds were identified that delay aggregation and unfolding under stress conditions.
• Excipients notably improved the thermal stability of toxoids adsorbed onto Alhydrogel.

Conclusions:

• The study identified effective stabilizers for Clostridium difficile toxoids A and B.
• Findings provide valuable data for designing pharmaceutical formulations with enhanced physical stability.
• This research contributes to the development of more robust and effective vaccines.